5-HT7 receptor antagonists

A technology of isomers and solvates, applied in the field of 5-HT7 receptor antagonists, can solve the problems of unreported activity and low sequence homology

Inactive Publication Date: 2007-08-08
LAB DEL DR ESTEVE SA
View PDF8 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] 5-HT 7 The receptor has been cloned from rat, mouse, guinea pig and human cDNA and shows a high degree of interspecies homology (approximately 95%), but is unique in that it has low sequence identity with other 5-HT recept

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 5-HT7 receptor antagonists
  • 5-HT7 receptor antagonists
  • 5-HT7 receptor antagonists

Examples

Experimental program
Comparison scheme
Effect test

Embodiment A

[0120] Synthesis of compounds of general formula (II)

[0121]

[0122] a) 2-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-propyl]-isoindole-1,3-dione

[0123] At room temperature, 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (6.89 g, 0.030 mol ), N-(3-bromopropyl)phthalimide (8.04g, 0.030mol), potassium carbonate (16.50g, 0.120mol) mixture was stirred overnight. The mixture was concentrated in vacuo and the residue was dissolved in water (120 mL) and extracted with ethyl acetate (3 x 30 mL), washed with water, the organic layer was dried and evaporated to give the product (10.85 g, 93% yield), which The product was used without further purification.

[0124] b) 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-propylamine dihydrochloride

[0125] 2-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-propyl]-isoindole-1,3-dione (10.46 g, 0.0275mol) and hydrazine hydrate (8.6mL, 0.275mol) in ethanol (250mL) were refluxed for 1 hour. The reaction mixtur...

Embodiment B

[0130] Compounds of general formula (I) are prepared by coupling compounds of general formula (II) with compounds of general formula (III) according to conventional methods of organic chemistry known to those skilled in the art.

[0131] 5-Chloro-N-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-propyl]-2,4-difluoro-benzenesulfonate Amide (Compound 48)

[0132]

[0133] 3-Chloro-4,6-difluorobenzenesulfonyl chloride (259 mg, 1.05 mmol) was added to 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl )-Propylamine dihydrochloride (323mg, 1mmol), N, N-diisopropylethylamine (517mg, 4mmol) CH 2 Cl 2 (15 mL) solution and stirred overnight at room temperature. The resulting solution was washed with water (3×20 mL), washed with Na 2 SO 4 The organic layer was dried and evaporated to dryness. The free base was dissolved in 2-propanol (5 mL). The product was crystallized in 2-propanol (5 mL) and collected by filtration and dried in vacuo to give a white solid (401 mg, 87%).

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Melting pointaaaaaaaaaa
Melting pointaaaaaaaaaa
Login to view more

Abstract

The invention relates to compounds of formula (I) having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Description

field of invention [0001] The present invention relates to compounds having pharmacological activity on 5-HT7 receptors, and more particularly to certain tetrahydroisoquinoline substituted sulfonamide compounds, to processes for the preparation of such compounds, and to pharmaceutical compositions comprising said compounds , and their therapeutic use, especially for the treatment and / or prevention of 5-HT such as CNS disorders 7 disease involved. Background of the invention [0002] In recent years, the search for new therapeutic agents has been greatly assisted by a better understanding of the structures of proteins and other biomolecules associated with target diseases. An important class of proteins that has been the subject of extensive research is the serotonin (serotonin, 5-HT) receptor family. 5-HT discovered in 1993 7 Receptors belong to this family and have attracted great attention as valuable new drug targets (Terrón, J.A. Idrugs, 1998, vol.1, no.3, pages 302-3...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D217/04C07D409/12C07D413/14C07D401/12C07D513/04C07D413/12C07D417/12A61K31/47A61K31/4725A61P25/00
CPCC07D217/04C07D401/12C07D413/14C07D409/12C07D405/12C07D513/04C07D417/12C07D409/14C07D413/12A61P1/04A61P9/00A61P9/12A61P13/02A61P13/10A61P25/00A61P25/04A61P25/06A61P25/18A61P25/20A61P25/22A61P25/24A61P25/28A61P43/00A61K31/47A61K31/4725
Inventor 安东尼·托伦斯霍维尔何塞普·马斯普里奥苏珊娜·耶内斯明格斯莫妮卡·加希尔洛佩斯埃尔伯特·多达尔卓尔拉斯卢斯·罗麦罗阿隆索赫尔穆特·H·布施曼
Owner LAB DEL DR ESTEVE SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap